NCT04287283Active, not recruiting
Cognitive Profile of Patients at the Sagol Center for Hyperbaric Medicine and Research
The Profile of Cognitive Function of Patients Who Had Neurocognitive Evaluation at the Sagol Center for Hyperbaric Medicine and Research
Source: ClinicalTrials.gov · Last updated 21 Apr 2026
Brief summary (registry, in English)
In the investigator's institute there is ongoing treatment of different patients with cognitive deficits using Hyperbaric oxygen therapy (HBOT). These patients undergo neuro-cognitive function computerized tests before and after treatment. The aim of this study was to retrospectively evaluate the cognitive changes before and after HBOT in different patients populations.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 2500 (actual)
- First submitted
- 25 Feb 2020
- Start date
- Jan 2008
- Primary completion date
- Dec 2030
- Lead sponsor
- Assaf-Harofeh Medical Center
- Diseases
- Stroke
- NCT number
- NCT04287283
What you commit to
- Study type: Observational
- Participants enrolled: 2500
- From Jan 2008 to the primary completion date, Dec 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patients who were not able to complete two cognitive tests
Who the study is looking for
- Patients included if they completed at least two neuro-cognitive computerized tests, before and after HBOT
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| hyperbaric center Asaf harofe medical center Coordinator of this site? Confirm its status | Rishon LeZiyyon | Israel | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.